IFN-α14 and select other type I interferons demonstrate potent in vitro antiviral activity against Enterovirus 71 compared to conventional IFN-α2a.
No takes yet. Share an insight, caveat, or question.
IFN-α14 merits preclinical exploration for EV71; leaves open human efficacy, safety, and clinical translation.
Yi et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: